166 related articles for article (PubMed ID: 36639578)
1. Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy.
Martin A; Cros J; Vullierme MP; Dokmak S; Sauvanet A; Levy P; Rebours V; Maire F
Surg Endosc; 2023 May; 37(5):3684-3690. PubMed ID: 36639578
[TBL] [Abstract][Full Text] [Related]
2. Can contrast-enhanced harmonic endoscopic ultrasonography accurately diagnose main pancreatic duct involvement in intraductal papillary mucinous neoplasms?
Ohno E; Kawashima H; Ishikawa T; Iida T; Suzuki H; Uetsuki K; Yashika J; Yamada K; Yoshikawa M; Gibo N; Aoki T; Kataoka K; Mori H; Hirooka Y; Fujishiro M
Pancreatology; 2020 Jul; 20(5):887-894. PubMed ID: 32651080
[TBL] [Abstract][Full Text] [Related]
3. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
[TBL] [Abstract][Full Text] [Related]
5. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
[TBL] [Abstract][Full Text] [Related]
6. Threshold of Main Pancreatic Duct Diameter in Identifying Malignant Intraductal Papillary Mucinous Neoplasm by Magnetic Resonance Imaging.
Zhang H; Cao Y; Ren S; Guo K; Zhang Y; Lin T; Wang Y; Chen X; Wang Z
Technol Cancer Res Treat; 2023; 22():15330338231170942. PubMed ID: 37078135
[No Abstract] [Full Text] [Related]
7. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
[TBL] [Abstract][Full Text] [Related]
8. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
[TBL] [Abstract][Full Text] [Related]
9. Prediction of malignancy in main duct or mixed-type intraductal papillary mucinous neoplasms of the pancreas.
Jung HS; Han Y; Kang JS; Sohn H; Lee M; Lee KB; Kim H; Kwon W; Jang JY
J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1014-1024. PubMed ID: 35451206
[TBL] [Abstract][Full Text] [Related]
10. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
[TBL] [Abstract][Full Text] [Related]
11. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
12. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
[TBL] [Abstract][Full Text] [Related]
14. Main Duct Dilatation Is the Best Predictor of High-grade Dysplasia or Invasion in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Del Chiaro M; Beckman R; Ateeb Z; Orsini N; Rezaee N; Manos L; Valente R; Yuan C; Ding D; Margonis GA; Yin L; Cameron JL; Makary MA; Burkhart RA; Weiss MJ; He J; Arnelo U; Yu J; Wolfgang CL
Ann Surg; 2020 Dec; 272(6):1118-1124. PubMed ID: 30672797
[TBL] [Abstract][Full Text] [Related]
15. Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
Ecker BL; Dickinson SM; Saadat LV; Tao AJ; Pulvirenti A; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Jarnagin WR; Wei AC; Gonen M; Soares KC
Ann Surg; 2023 Jul; 278(1):110-117. PubMed ID: 35950775
[TBL] [Abstract][Full Text] [Related]
16. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
[TBL] [Abstract][Full Text] [Related]
17. Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms.
Crippa S; Pergolini I; Rubini C; Castelli P; Partelli S; Zardini C; Marchesini G; Zamboni G; Falconi M
Surgery; 2016 Apr; 159(4):1041-9. PubMed ID: 26704784
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
[TBL] [Abstract][Full Text] [Related]
19. Predictors of malignancy in main duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Abe Y; Kai Y; Takada R; Yamai T; Nakabori T; Ikezawa K; Takahashi H; Ohkawa K
Gastrointest Endosc; 2022 Feb; 95(2):291-296. PubMed ID: 34474037
[TBL] [Abstract][Full Text] [Related]
20. Importance of main pancreatic duct dilatation in IPMN undergoing surveillance.
Marchegiani G; Andrianello S; Morbin G; Secchettin E; D'Onofrio M; De Robertis R; Malleo G; Bassi C; Salvia R
Br J Surg; 2018 Dec; 105(13):1825-1834. PubMed ID: 30106195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
